Schlieper G - Search Results

1

[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Schlieper G, Schwenger V, Remppis A, Keller T, Dechend R, Massberg S, Baldus S, Weinreich T, Hetzel G, Floege J, Mahfoud F, Fliser D. Schlieper G, et al. Internist (Berl). 2017 May;58(5):512-521. doi: 10.1007/s00108-017-0220-5. Internist (Berl). 2017. PMID: 28396914 Review. German.

2

"Missing" inhibitors of calcification: general aspects and implications in renal failure.

Ketteler M, Westenfeld R, Schlieper G, Brandenburg V, Floege J. Ketteler M, et al. Among authors: schlieper g. Pediatr Nephrol. 2005 Mar;20(3):383-8. doi: 10.1007/s00467-004-1614-x. Epub 2004 Nov 10. Pediatr Nephrol. 2005. PMID: 15549415 Review.

3

Calcification and cardiovascular health: new insights into an old phenomenon.

Ketteler M, Schlieper G, Floege J. Ketteler M, et al. Among authors: schlieper g. Hypertension. 2006 Jun;47(6):1027-34. doi: 10.1161/01.HYP.0000219635.51844.da. Epub 2006 Apr 17. Hypertension. 2006. PMID: 16618842 Review. No abstract available.

4

[Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?].

Schlieper G, Brandenburg V, Djuric Z, Damjanovic T, Markovic N, Westenfeld R, Dimkovic N, Ketteler M, Floege J. Schlieper G, et al. Dtsch Med Wochenschr. 2007 Sep;132(36):1820-4. doi: 10.1055/s-2007-984969. Dtsch Med Wochenschr. 2007. PMID: 17726653 German.

5

Calcimimetics in CKD-results from recent clinical studies.

Schlieper G, Floege J. Schlieper G, et al. Pediatr Nephrol. 2008 Oct;23(10):1721-8. doi: 10.1007/s00467-008-0900-4. Epub 2008 Jul 2. Pediatr Nephrol. 2008. PMID: 18594867 Free PMC article. Review.

6

Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.

Schlieper G, Brandenburg V, Ketteler M, Floege J. Schlieper G, et al. Nat Rev Nephrol. 2009 Sep;5(9):539-43. doi: 10.1038/nrneph.2009.99. Nat Rev Nephrol. 2009. PMID: 19701230 Review.

7

Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.

Brandenburg VM, Schlieper G, Heussen N, Holzmann S, Busch B, Evenepoel P, Vanholder R, Meijers B, Meert N, Fassbender WJ, Floege J, Jahnen-Dechent W, Ketteler M. Brandenburg VM, et al. Among authors: schlieper g. Nephrol Dial Transplant. 2010 Aug;25(8):2672-9. doi: 10.1093/ndt/gfq053. Epub 2010 Feb 18. Nephrol Dial Transplant. 2010. PMID: 20172849

8

Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients.

Krüger T, Brandenburg V, Schlieper G, Marx N, Floege J. Krüger T, et al. Among authors: schlieper g. Nephrol Dial Transplant. 2013 Mar;28(3):534-41. doi: 10.1093/ndt/gfs485. Epub 2012 Nov 23. Nephrol Dial Transplant. 2013. PMID: 23180880 Review.

9

Atrial fibrillation and chronic kidney disease.

Schlieper G, Krüger T, Floege J. Schlieper G, et al. N Engl J Med. 2012 Nov 29;367(22):2157; author reply 2158-9. doi: 10.1056/NEJMc1212362. N Engl J Med. 2012. PMID: 23190235 No abstract available.

10

Chronic kidney disease: How effective and safe are antiplatelet agents in CKD?

Floege J, Schlieper G. Floege J, et al. Among authors: schlieper g. Nat Rev Nephrol. 2013 Jun;9(6):314-6. doi: 10.1038/nrneph.2013.83. Epub 2013 Apr 30. Nat Rev Nephrol. 2013. PMID: 23629644 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters